| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

First dolutegravir 10mg dispersible tablet prequalified

M

Announcement

14 December, 2021 - 22:00 (CET)

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

WHO list of SARS-CoV-2 IVDS currently under assessment for Emergency Use Listing updated

IVD

Announcement

14 December, 2021 - 12:00 (CET)

New WHO Public Inspection Report (WHOPIR) published

IS

Announcement

14 December, 2021 - 11:30 (CET)

HIV rapid tests under assessment updated

IVD

Announcement

10 December, 2021 - 12:00 (CET)

WHO list of SARS-CoV-2 IVDS currently under assessment for Emergency Use Listing updated

IVD

Announcement

10 December, 2021 - 11:30 (CET)

List of IVDs that were not accepted under WHO Emergency Use Listing for SARS-CoV-2

IVD

Announcement

10 December, 2021 - 11:00 (CET)

WHO list of SARS-CoV-2 IVDS currently under assessment for Emergency Use Listing updated

IVD

Announcement

7 December, 2021 - 12:30 (CET)

Newly prequalified Active Pharmaceutical Ingredient (API)

M

Announcement

7 December, 2021 - 12:09 (CET)

Ritonavir (WHOAPI-398) manufactured by Laurus Labs Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification procedure.

New WHO Public Inspection Report (WHOPIR) published

IS

Announcement

7 December, 2021 - 12:00 (CET)

Newly prequalified Active Pharmaceutical Ingredient (API)

M

Announcement

1 December, 2021 - 16:30 (CET)

Subscribe to